235 results
DEFA14A
TXMD
TherapeuticsMD Inc
17 May 23
Additional proxy soliciting materials
5:05pm
Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2))
Definitive Proxy Statement
Definitive Additional Materials
Soliciting … , if other than the Registrant)
Payment of Filing Fee (Check the appropriate box):
No fee required.
Fee paid previously with preliminary materials.
Fee
8-K
gia1nkyhs
21 Apr 23
Other Events
5:14pm
8-K
EX-10.2
rbvs6
5 Dec 22
TherapeuticsMD Announces Definitive Agreements to License its Products to Mayne Pharma
7:31am
8-K
EX-10.1
2nt2uwb4sjr876 2i3a
5 Dec 22
TherapeuticsMD Announces Definitive Agreements to License its Products to Mayne Pharma
7:31am
D
bf48q8
14 Nov 22
$7.00 mm in equity / options / securities to be acquired, sold $7.00 mm, 6 investors
4:51pm
8-K
EX-10.2
91l4n4gxgfb j2u
31 Oct 22
TherapeuticsMD Announces Additional $7 Million Private Placement
7:00am
8-K
EX-10.1
i2vxhx92mwxb y1y
31 Oct 22
TherapeuticsMD Announces Additional $7 Million Private Placement
7:00am
D
qrrg27
17 Oct 22
$7.00 mm in equity / options / securities to be acquired, sold $7.00 mm, 6 investors
4:36pm
8-K
EX-10.1
qp4eieimoj
3 Oct 22
TherapeuticsMD Announces $7 Million Private Placement
7:00am
8-K
EX-10.2
fs7sc 430ocm77ks
3 Oct 22
TherapeuticsMD Announces $7 Million Private Placement
7:00am
D
teni5zkg i9u
15 Aug 22
$15M in equity / options / securities to be acquired, sold $15M, 6 investors
8:08pm